regulation is the sole category represented across all 1 tracked stories. Of the tracked stories, 1 of 1 also mention Biogen, the most common co-covered peer. We currently track 1 Healthcare story that mention Emily Felix, all published on August 3, 2026.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about Emily Felix
regulation is the sole category represented across all 1 tracked stories. Of the tracked stories, 1 of 1 also mention Biogen, the most common co-covered peer. We currently track 1 Healthcare story that mention Emily Felix, all published on August 3, 2026. Each carries 2 original sources on average.
Stories tracked
1
Sources per story
2
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 16 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering Emily Felix. Shared-story counts are live from our verified record — not editorial picks.
A woman with Friedreich’s ataxia sues the HSE over an unacceptably prolonged reimbursement decision for omaveloxolone, a treatment that could slow her decline and that is already standard care in 12 other European countries.